| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |